Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Folker Westphal

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Forensic Science International|April 7, 2009
Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazineFolker Westphal, Thomas Junge, Ulrich Girreser, et al.
Metabolites|December 23, 2022
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MSSelina Hemmer, Lea Wagmann, Benedikt Pulver, et al.
Forensic Science International|September 12, 2006
Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenoneFolker Westphal, Thomas Junge, Peter Rösner, et al.
Journal of Mass Spectrometry : JMS|February 24, 2012
Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'Stefan Kneisel, Folker Westphal, Philippe Bisel, et al.
Archiv Fur Kriminologie|June 5, 2002
[Fatal outcome of poisoning with the benzodiazepines flunitrazepam and diazepam]Björn Ahrens, Gertrud Rochholz, Folker Westphal, et al.
Archives of Toxicology|July 5, 2022
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.
Journal of Mass Spectrometry : JMS|September 22, 2010
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compoundsSebastian Dresen, Nerea Ferreirós, Michael Pütz, et al.
Forensic Science International|January 24, 2012
Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography systemBjoern Moosmann, Stefan Kneisel, Ulrich Girreser, et al.
Drug Testing and Analysis|December 23, 2018
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)Bjoern Moosmann, Philippe Bisel, Folker Westphal, et al.
Talanta|July 22, 2018
Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamineAchim T Caspar, Markus R Meyer, Folker Westphal, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Forensic Science International|April 7, 2009
Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazineFolker Westphal, Thomas Junge, Ulrich Girreser, et al.
Metabolites|December 23, 2022
In Vitro and In Vivo Toxicometabolomics of the Synthetic Cathinone PCYP Studied by Means of LC-HRMS/MSSelina Hemmer, Lea Wagmann, Benedikt Pulver, et al.
Forensic Science International|September 12, 2006
Mass spectral and NMR spectral data of two new designer drugs with an alpha-aminophenone structure: 4'-methyl-alpha-pyrrolidinohexanophenone and 4'-methyl-alpha-pyrrolidinobutyrophenoneFolker Westphal, Thomas Junge, Peter Rösner, et al.
Journal of Mass Spectrometry : JMS|February 24, 2012
Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'Stefan Kneisel, Folker Westphal, Philippe Bisel, et al.
Archiv Fur Kriminologie|June 5, 2002
[Fatal outcome of poisoning with the benzodiazepines flunitrazepam and diazepam]Björn Ahrens, Gertrud Rochholz, Folker Westphal, et al.
Archives of Toxicology|July 5, 2022
Going deeper into the toxicokinetics of synthetic cannabinoids: in vitro contribution of human carboxylesterasesLea Wagmann, Rebecca G Stiller, Svenja Fischmann, et al.
Journal of Mass Spectrometry : JMS|September 22, 2010
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compoundsSebastian Dresen, Nerea Ferreirós, Michael Pütz, et al.
Forensic Science International|January 24, 2012
Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography systemBjoern Moosmann, Stefan Kneisel, Ulrich Girreser, et al.
Drug Testing and Analysis|December 23, 2018
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)Bjoern Moosmann, Philippe Bisel, Folker Westphal, et al.
Talanta|July 22, 2018
Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamineAchim T Caspar, Markus R Meyer, Folker Westphal, et al.
Pageof 7